Lipigon Pharmaceuticals AB (publ) (LPGO.ST)

SEK 0.17

(-4.69%)

Eps Summary of Lipigon Pharmaceuticals AB (publ)

  • Lipigon Pharmaceuticals AB (publ)'s latest annual eps in 2023 was -0.19 SEK , up 91.04% from previous year.
  • Lipigon Pharmaceuticals AB (publ)'s latest quarterly eps in 2024 Q2 was -0.00 SEK , up 94.55% from previous quarter.
  • Lipigon Pharmaceuticals AB (publ) reported an annual eps of -2.12 SEK in 2022, up 36.72% from previous year.
  • Lipigon Pharmaceuticals AB (publ) reported an annual eps of -3.35 SEK in 2021, down -142.75% from previous year.
  • Lipigon Pharmaceuticals AB (publ) reported a quarterly eps of -0.06 SEK for 2024 Q1, up 33.45% from previous quarter.
  • Lipigon Pharmaceuticals AB (publ) reported a quarterly eps of N/A for 2023 FY, up 91.04% from previous quarter.

Annual Eps Chart of Lipigon Pharmaceuticals AB (publ) (2023 - 2017)

Historical Annual Eps of Lipigon Pharmaceuticals AB (publ) (2023 - 2017)

Year Eps Eps Growth
2023 -0.19 SEK 91.04%
2022 -2.12 SEK 36.72%
2021 -3.35 SEK -142.75%
2020 -1.38 SEK -245.0%
2019 -0.40 SEK -33.33%
2018 -0.30 SEK 99.94%
2017 -470.17 SEK 0.0%

Peer Eps Comparison of Lipigon Pharmaceuticals AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 65.455%
Ziccum AB (publ) -1.54 SEK 87.662%
Modus Therapeutics Holding AB (publ) -1.01 SEK 81.188%
BioArctic AB (publ) 2.60 SEK 107.308%
Sprint Bioscience AB (publ) -0.01 SEK -2915.873%
Mendus AB (publ) -4.40 SEK 95.682%
Genovis AB (publ.) 0.94 SEK 120.213%
Intervacc AB (publ) -1.69 SEK 88.757%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 13.636%
Active Biotech AB (publ) -0.17 SEK -11.765%
Magle Chemoswed Holding AB (publ) 1.13 SEK 116.814%
Bio-Works Technologies AB (publ) -1.57 SEK 87.898%
Aptahem AB (publ) -0.05 SEK -293.375%
Vicore Pharma Holding AB (publ) -3.22 SEK 94.099%
Kancera AB (publ) -0.80 SEK 76.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 98.09%
Fluicell AB (publ) -0.24 SEK 20.833%
Saniona AB (publ) -1.29 SEK 85.271%
Biovica International AB (publ) -2.14 SEK 91.121%
Spago Nanomedical AB (publ) -0.43 SEK 55.814%
AcouSort AB (publ) -1.29 SEK 85.271%
Xintela AB (publ) -0.13 SEK -46.154%
Abliva AB (publ) -0.09 SEK -110.177%
Egetis Therapeutics AB (publ) -1.27 SEK 85.039%
Karolinska Development AB (publ) 0.02 SEK 1050.0%
OncoZenge AB (publ) -1.36 SEK 86.029%
Amniotics AB (publ) -0.01 SEK -1627.273%
2cureX AB (publ) -1.85 SEK 89.73%
CombiGene AB (publ) -1.80 SEK 89.444%
Asarina Pharma AB (publ) -0.57 SEK 66.667%
Calliditas Therapeutics AB (publ) -8.69 SEK 97.814%
Camurus AB (publ) 7.78 SEK 102.442%
Corline Biomedical AB -0.08 SEK -125.653%
IRLAB Therapeutics AB (publ) -3.43 SEK 94.461%
Isofol Medical AB (publ) -0.23 SEK 17.391%
I-Tech AB 1.70 SEK 111.176%
Hansa Biopharma AB (publ) -15.83 SEK 98.8%
Cyxone AB (publ) -0.22 SEK 13.636%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 90.404%
Biosergen AB -0.60 SEK 68.333%
Cantargia AB (publ) -1.65 SEK 88.485%
NextCell Pharma AB -1.03 SEK 81.553%
Xspray Pharma AB (publ) -6.76 SEK 97.189%
Elicera Therapeutics AB (publ) -0.83 SEK 77.108%
Nanologica AB (publ) -2.05 SEK 90.732%
SynAct Pharma AB -6.64 SEK 97.139%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 26.923%
Stayble Therapeutics AB (publ) -0.92 SEK 79.348%
LIDDS AB (publ) -0.63 SEK 69.841%
Lipum AB (publ) -4.45 SEK 95.73%
BioInvent International AB (publ) -5.02 SEK 96.215%
Alzinova AB (publ) -0.41 SEK 53.659%
Oncopeptides AB (publ) -1.96 SEK 90.306%
Pila Pharma AB (publ) -0.47 SEK 59.574%
Guard Therapeutics International AB (publ) -11.26 SEK 98.313%
Scandinavian ChemoTech AB (publ) -1.13 SEK 83.186%
Simris Alg AB (publ) -0.16 SEK -18.75%
Diamyd Medical AB (publ) -1.60 SEK 88.125%
Xbrane Biopharma AB (publ) -1.27 SEK 85.039%
Ascelia Pharma AB (publ) -3.24 SEK 94.136%
Diagonal Bio AB (publ) -0.32 SEK 40.625%